(02575): The offering price per share is 11.6 Hong Kong dollars. The Hong Kong public offering has been oversubscribed 4,908.33 times.
Xuanzhu Biology-B (02575) announced the distribution results, with the company offering a total of 67.3335 million H shares globally. In Hong Kong...
(02575) publicly announces the distribution results. The company globally issued 67.3335 million H shares, with 10% allocated for public offering in Hong Kong and 90% for international offering. The sale price per share is HK$11.6, with a net proceeds of approximately HK$701 million from the global offering. Each lot consists of 500 shares, and it is expected that the H shares will start trading on the Stock Exchange on Wednesday, October 15, 2025, at 9:00 am (Hong Kong time).
In Hong Kong, the public offering received 4,908.33 times oversubscription, while the international offering received 10.15 times oversubscription.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


